Clinical Trials Logo

Filter by:
NCT ID: NCT01347905 Completed - Obesity Clinical Trials

Changes in Iron Absorption and Availability Before and After Weight Loss in Obese Pre-menopausal Women and Men.

Start date: February 2011
Phase: N/A
Study type: Observational

The objective of this study is to investigate if weight loss, in particular due to adipose tissue loss, in obese patients will reverse the obesity-related reduction of iron absorption, and if this is due to a decrease in hepcidin concentrations. Additionally, the investigators will investigate changes in iron incorporation into erythrocytes due to a reduction of iron sequestration by the adipose tissue and reticuloendothelial system. The investigators expect that by decreasing adiposity, circulating hepcidin levels will decrease, iron absorption and incorporation into erythrocytes will increase and as a result iron status will be improved.

NCT ID: NCT01345929 Completed - Pyelonephritis Clinical Trials

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis

Start date: June 20, 2011
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, prospective, randomized, double-blind, double dummy study of CXA 201 IV infusions (1500 mg q8h) versus levofloxacin IV infusions (750 mg qd) for the treatment of adults with a cUTI (including pyelonephritis).

NCT ID: NCT01345682 Completed - Clinical trials for Head and Neck Neoplasms

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Start date: January 5, 2012
Phase: Phase 3
Study type: Interventional

This randomised, open-label, phase III study will be performed in patients with R/M head and neck squamous cell carcinoma (HNSCC) who have progressed after platinum-based therapy. The objectives of the trial are to compare the efficacy and safety of afatinib versus methotrexate

NCT ID: NCT01345669 Terminated - Clinical trials for Head and Neck Neoplasms

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Start date: October 17, 2011
Phase: Phase 3
Study type: Interventional

This randomised, double-blind phase III trial will be performed in patients with head and neck squamous cell carcinoma (HNSCC). The objectives of the trial are to compare the efficacy and safety of afatinib (BIBW 2992) with placebo as adjuvant therapy to patients who have received definitive chemo-radiotherapy.

NCT ID: NCT01345045 Completed - Clinical trials for Diabetic Neuropathic Pain

A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain

Start date: April 2011
Phase: Phase 2
Study type: Interventional

People with diabetes can, over time develop nerve damage throughout the body with symptoms such as pain, tingling, or numbness (loss of feeling) in the hands, arms, feet and legs.

NCT ID: NCT01342666 Completed - Clinical trials for Hypoalphalipoproteinemia

Tomato Consumption and High Density Lipoprotein-cholesterol

Start date: March 2009
Phase: N/A
Study type: Interventional

- This is a randomized, open-label, single blind, clinical trial - The study evaluated the effect of tomato consumption in serum HDL-cholesterol levels. - The hypothesis was that two daily tomatoes during one month will increase the HDL-c levels. - Since a placebo of tomatoes cannot be done, the control group will receive same proportion of cucumber because 1) it was not possible to have a tomato placebo; 2) cucumber does not have any lycopene; 3) both can be prepared similarly; and 4) the required quantity can be measured in the same way. - The intervention was during 1 month and was assigned by randomization. - Personnel who did the clinical and biochemical evaluation were blinded for the intervention. - Lipid profile was measured before and after the intervention. - Confounding factors such as daily physical activity, diet, consumption of fish or alcoholic beverages, smoking status were considered during statistical analyses.

NCT ID: NCT01342588 Unknown status - Clinical trials for Spine Pedicle Screw Placement

Accuracy of Lumbar Pedicle Screw Placement Assisted With Continuous Pulse-train Stimulation

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to establish the accuracy of pedicle positioning using continuous electrical pulse during screwing. Additionally, the investigators evaluate if this maneuver can prevent neurological injury during track creation and screwing in lumbar and thoracic spine instrumentation surgery

NCT ID: NCT01342575 Recruiting - Clinical trials for Cervical Disk Disease

Improvement of Trans-operatory X-ray Visualization During Anterior Cervical Surgery

Start date: December 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to establish which of five different maneuvers could bring the best trans-operatory x-ray exposure during anterior cervical surgeries with the higher security

NCT ID: NCT01342484 Completed - Clinical trials for Diabetes Mellitus, Type 2

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

Start date: April 2011
Phase: Phase 2
Study type: Interventional

The main objective of this study is to identify the dose of linagliptin in paediatric patients. Other efficacy objectives include the comparison of the lowering effect of linagliptin low dose, high dose and placebo on the fasting plasma glucose (FPG) observed after 12 wk of treatment. Furthermore, the study will investigate the pharmacokinetics (PK), the pharmacodynamics (PD) and the PK/PD relationship of linagliptin in the paediatric population.

NCT ID: NCT01340898 Completed - Clinical trials for Meningococcal Infection

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

Start date: January 27, 2012
Phase: Phase 3
Study type: Interventional

This study evaluates the immunogenicity and safety of the meningococcal conjugate vaccine GSK 134612 in healthy infants, when co-administered with other infant vaccines, on three different dose schedules.